Effects of adagrasib: A Synthesis of Findings from 3 Studies
- Home
- Effects of adagrasib
This analysis is based on research papers included in PubMed, but medical research is constantly evolving and may not fully reflect the latest findings. There may also be biases towards certain research areas.
This information is not medical advice and is not a substitute for diagnosis or treatment by a physician. If you have concerns about "Effects of adagrasib: A Synthesis of Findings from 3 Studies", please consult your doctor.
For NLM copyright information, please see Link to NLM Copyright Page
PubMed data is obtained via Hugging Face Datasets: Link to DatasetPlease check the disclaimer.
Major Research Findings
Albendazole has been shown to be an effective treatment for various parasitic infections. A study involving 112 patients with gnathostomiasis found that albendazole, administered at a dosage of 400mg twice daily or once daily, led to cure in 93.9% and 94.1% of patients, respectively, compared to none in the placebo group. 1 . Additionally, a placebo-controlled study involving 870 patients with intestinal helminthiasis demonstrated high efficacy of albendazole against roundworms and tapeworms. 2 . However, albendazole has also been linked to liver injury. A systematic review encompassing 12 cases reported jaundice, anorexia, and vomiting as common symptoms following albendazole use, with elevated liver enzymes observed in all cases. 3 .
Benefits and Risks
Benefit Summary
Albendazole is a widely used antiparasitic medication that has demonstrated efficacy in treating gnathostomiasis, various intestinal helminth infections, and even strongyloidiasis. 1 , 2 . The drug generally exhibits minimal side effects, which are often temporary. 1 , 2 .
Risk Summary
Albendazole use carries a risk of liver injury, even at relatively low doses. 3 . Symptoms such as jaundice, anorexia, and vomiting have been reported in individuals following albendazole administration. 3 .
Comparison Across Studies
Commonalities
All three studies focused on evaluating the efficacy and safety of albendazole. 1 , 2 , 3 . They consistently demonstrated the effectiveness of albendazole in treating parasitic infections. 1 , 2 , 3 .
Differences
The studies differed in their target diseases and administration methods. 1 investigated the treatment of gnathostomiasis, while 2 focused on various intestinal helminth infections. 3 specifically evaluated the risk of liver injury associated with albendazole use.
Consistency and Contradictions
While all three studies indicated the effectiveness of albendazole, one study highlighted the potential for liver injury as a side effect. 3 . It's crucial to recognize this risk and follow medical advice closely when using albendazole.
Practical Implications and Cautions
It's essential to adhere to medical guidance when using albendazole, as self-administration can increase the risk of liver injury. 3 . Additionally, pregnant and breastfeeding women should avoid albendazole use. 1 , 2 .
Current Research Limitations
Further research is needed to assess the long-term effectiveness and safety of albendazole. 1 , 2 , 3 . Additional research is also crucial to develop strategies for minimizing the risk of side effects associated with albendazole use.
Future Research Directions
Future research should focus on the long-term effects and safety of albendazole, strategies to minimize side effects, and its safety during pregnancy and breastfeeding.
Conclusion
Albendazole is an effective treatment for a range of parasitic infections. 1 , 2 . However, it's essential to be aware of the risk of liver injury. 3 . Always follow medical guidance when using albendazole to minimize the risk of side effects.
Article Type
Author: KraivichianP, KulkumthornM, YingyourdP, AkarabovornP, PaireepaiC C
Language : English
Author: RossignolJ F, MaisonneuveH
Language : English
Language : English
This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.